COBO MARC (Principal Accounting Officer) reported 1 transaction at BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 10/23/2026ACC: 0001193125-26-430449
Officer· Principal Accounting Officer
Since Apr 2026
-203.00
Net shares
Net seller
$544.04
Total sold
0
Open market trades
0B · 0S
1
Total transactions
203.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−203.00
Price / share
$2.68
Trade value
$544.04
% of position
1.4%
10/21/2026
14.02K→13.81K
Total
Net shares
−203.00
Net value
-$544.04
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/21/2026 | F · Tax Withholding | −203.00 | $2.68 | $544.04 | 1.4% | 14.02K | 13.81K |
| Total | −203.00 | -$544.04 | ||||||
Derivative Transactions0
No derivative transactions reported